{"id":345187,"date":"2026-11-12T15:45:12","date_gmt":"2026-11-12T10:15:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-pat-667-crore\/"},"modified":"2026-11-12T15:45:12","modified_gmt":"2026-11-12T10:15:12","slug":"alkem-laboratories-q2-results-fy27-pat-667-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q2-results-fy27-pat-667-crore\/","title":{"rendered":"Alkem Laboratories Q2 Results FY27: Revenue Rises 13.77% to Rs 4,551.99 Cr, PAT Rs 667.13 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Alkem Laboratories Q2 Results FY27 were declared on 12 November 2026 and cover the July to September 2026 quarter on a consolidated basis. Revenue rose 13.77% YoY to Rs 4,551.99 Cr from Rs 4,000.99 Cr, which is clear YoY growth in the quarterly results. Net profit was Rs 667.13 Cr against Rs 779.11 Cr a year earlier, a fall of 14.37% YoY.<\/p>\n<\/div>\n

Alkem Laboratories Ltd<\/a> (ALKEM) Q2 Results FY27 announced on 12 November 2026, covering the company’s financial performance for the July to September quarter. On the results date, the consolidated results showed revenue of Rs 4,551.99 Cr and PAT of Rs 667.13 Cr, and Alkem Laboratories Q2 Results FY27 also record Operating Profit of Rs 1,025.19 Cr. These are the numbers that investors tracking the stock on NSE and BSE will want to see first.<\/p>\n

This Alkem Laboratories Q2 Results review from Univest is a results analysis of the financial highlights, business drivers, outlook and risks behind the numbers. It begins with the Financial Highlights table below, which places this quarter beside the same quarter last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n